Market News
Stay updated with the latest market trends, earnings, and economic indicators.

Is buy-on-dips strategy truly working for mutual fund investors? Here's what past 2-year data reveal - Mint
Is buy-on-dips strategy truly working for mutual fund investors? Here's what past 2-year data revealMint
Expert View | Retail investors should prioritise portfolio resilience over aggression: Siddhartha Khemka, Motilal Oswal - Mint
Expert View | Retail investors should prioritise portfolio resilience over aggression: Siddhartha Khemka, Motilal OswalMint
Is your mutual fund SIP secretly crushing the Indian rupee? Jefferies explains the bitter side of the story
India's strong mutual fund SIP culture is helping foreign investors exit the equity market. This is putting pressure on the Indian Rupee. Jefferies reports that capital flows are low, not the current account deficit. Foreign investors have sold equities worth billions. Domestic savings are now funding these outflows. The Rupee is undervalued, but a rebound is possible.
Is your mutual fund SIP secretly crushing the Indian rupee? Jefferies explains the bitter side of the story - The Economic Times
Is your mutual fund SIP secretly crushing the Indian rupee? Jefferies explains the bitter side of the storyThe Economic Times

Jubilant FoodWorks: Target Slashed; Motilal Oswal Stays Neutral on Soft Q4 Results — Check Upside
Motilal Oswal has trimmed its target price on Jubilant FoodWorks, while maintaining a Neutral' rating, citing a weak Q4 performance and continued near-term pressure on margins.

Six out of 16 Lenskart analysts see the stock beyond ₹600 after Q4 results; Details here
Equirus Securities has the highest target for Lenskart at ₹662, followed by Motilal Oswal at ₹650. Axis Capital, Goldman Sachs, Emkay and Jefferies make up that list.
Analyst shares 3 must have stocks for your portfolio; key reasons inside
Ruchit Jain on Motilal Oswal recommends buying the shares of Manappuram Finance, Angle One, and Siemens Energy today

Lenskart Sees Target Price Hike After Q4 Beat — Check Upside, Key Triggers and More By Motilal Oswal
Lenskart remains a well-positioned consumer-tech play with scalable growth drivers, supported by its integrated business model and expanding global footprint: Motilal Oswal
Edelweiss MF unveils second SIF offering; Parle confusion lifts stock
Edelweiss Mutual Fund launched its second specialised investment fund offering, while shares of Parle Industries surged after traders mistook it for the maker of Melody toffees
Sebi may allow third-party payments in mutual funds, ease transaction norms
The proposal marks a departure from current regulations that require that all mutual fund transactions must happen with the investor’s verified bank accounts, to enable maintenance of a digital trail.

Akums Drugs, subsidiary Akumentis Healthcare face ₹134 crore Income Tax demand
Shares of Akums Drugs and Pharmaceuticals Ltd ended at ₹513.00, down by ₹6.70, or 1.29%, on the BSE.

SEBI Proposes Allowing Investment In Mutual Funds Via Salary Deductions
The regulator has also proposed permitting mutual fund distributors to receive commissions in the form of mutual fund units.